Ann Lovett

1.2k total citations
20 papers, 851 citations indexed

About

Ann Lovett is a scholar working on Cardiology and Cardiovascular Medicine, Economics and Econometrics and Surgery. According to data from OpenAlex, Ann Lovett has authored 20 papers receiving a total of 851 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 10 papers in Economics and Econometrics and 9 papers in Surgery. Recurrent topics in Ann Lovett's work include Coronary Interventions and Diagnostics (7 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers) and Acute Myocardial Infarction Research (6 papers). Ann Lovett is often cited by papers focused on Coronary Interventions and Diagnostics (7 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers) and Acute Myocardial Infarction Research (6 papers). Ann Lovett collaborates with scholars based in United States and Israel. Ann Lovett's co-authors include Sharon‐Lise T. Normand, Robert Wolf, Katya Zelevinsky, Laura Mauri, Treacy S. Silbaugh, Zheng Zhou, Manu Varma, David M. Shahian, Pallav Garg and Frederic S. Resnic and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Ann Lovett

18 papers receiving 813 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ann Lovett United States 15 583 435 153 143 119 20 851
Márcia Makdisse Brazil 13 499 0.9× 319 0.7× 139 0.9× 86 0.6× 94 0.8× 31 855
Michael O’Donnell United States 11 414 0.7× 273 0.6× 100 0.7× 97 0.7× 163 1.4× 20 848
Chee Tang Chin Singapore 17 936 1.6× 302 0.7× 202 1.3× 107 0.7× 50 0.4× 51 1.1k
John G. McGinnity United States 9 470 0.8× 276 0.6× 161 1.1× 81 0.6× 182 1.5× 16 879
Anthony C. De Franco United States 13 485 0.8× 556 1.3× 256 1.7× 112 0.8× 154 1.3× 23 921
Stanley W. Dziuban United States 11 555 1.0× 282 0.6× 58 0.4× 111 0.8× 144 1.2× 18 838
Troels Yndigegn Sweden 14 660 1.1× 220 0.5× 215 1.4× 81 0.6× 59 0.5× 44 1.0k
Patrick Magee United Kingdom 11 354 0.6× 337 0.8× 147 1.0× 73 0.5× 88 0.7× 17 661
Edwin Fonner United States 13 642 1.1× 406 0.9× 67 0.4× 63 0.4× 159 1.3× 20 891
Laura G. Qualls United States 15 398 0.7× 167 0.4× 109 0.7× 46 0.3× 120 1.0× 32 788

Countries citing papers authored by Ann Lovett

Since Specialization
Citations

This map shows the geographic impact of Ann Lovett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Lovett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Lovett more than expected).

Fields of papers citing papers by Ann Lovett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Lovett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Lovett. The network helps show where Ann Lovett may publish in the future.

Co-authorship network of co-authors of Ann Lovett

This figure shows the co-authorship network connecting the top 25 collaborators of Ann Lovett. A scholar is included among the top collaborators of Ann Lovett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann Lovett. Ann Lovett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shahian, David M., David F. Torchiana, Daniel T. Engelman, et al.. (2018). Mandatory public reporting of cardiac surgery outcomes: The 2003 to 2014 Massachusetts experience. Journal of Thoracic and Cardiovascular Surgery. 158(1). 110–124.e9. 19 indexed citations
2.
Normand, Sharon‐Lise T., et al.. (2016). Assessing Hospital Performance After Percutaneous Coronary Intervention Using Big Data. Circulation Cardiovascular Quality and Outcomes. 9(6). 659–669. 14 indexed citations
3.
Dehmer, Gregory, Jonathan Jennings, Ruth A. Madden, et al.. (2015). The National Cardiovascular Data Registry Voluntary Public Reporting Program. Journal of the American College of Cardiology. 67(2). 205–215. 23 indexed citations
4.
Yeh, Robert W., Laura Mauri, Robert Wolf, et al.. (2015). Population Trends in Rates of Coronary Revascularization. JAMA Internal Medicine. 175(3). 454–454. 29 indexed citations
5.
Yeh, Robert W., et al.. (2014). STEEP DECLINES IN POPULATION RATES OF CORONARY REVASCULARIZATION. Journal of the American College of Cardiology. 63(12). A1528–A1528.
6.
Albert, Michelle A., John Z. Ayanian, Treacy S. Silbaugh, et al.. (2014). Early Results of Massachusetts Healthcare Reform on Racial, Ethnic, and Socioeconomic Disparities in Cardiovascular Care. Circulation. 129(24). 2528–2538. 44 indexed citations
7.
Bangalore, Sripal, Treacy S. Silbaugh, Sharon‐Lise T. Normand, et al.. (2014). Drug‐eluting stents versus bare metal stents prior to noncardiac surgery. Catheterization and Cardiovascular Interventions. 85(4). 533–541. 4 indexed citations
8.
Yeh, Robert W., Samip Vasaiwala, Daniel E. Forman, et al.. (2013). Instrumental Variable Analysis to Compare Effectiveness of Stents in the Extremely Elderly. Circulation Cardiovascular Quality and Outcomes. 7(1). 118–124. 12 indexed citations
9.
Wasfy, Jason H., Kenneth Rosenfield, Katya Zelevinsky, et al.. (2013). A Prediction Model to Identify Patients at High Risk for 30-Day Readmission After Percutaneous Coronary Intervention. Circulation Cardiovascular Quality and Outcomes. 6(4). 429–435. 52 indexed citations
10.
Vasaiwala, Samip, Daniel E. Forman, Robert W. Yeh, et al.. (2012). SELECTIVE DRUG-ELUTING STENT USE IN ELDERLY PATIENTS: IMPACT ON PERCUTANEOUS CORONARY INTERVENTION MORTALITY AND BLEEDING RISK. Journal of the American College of Cardiology. 59(13). E1526–E1526. 2 indexed citations
11.
Yeh, Robert W., Kenneth Rosenfield, Katya Zelevinsky, et al.. (2012). Sources of Hospital Variation in Short-Term Readmission Rates After Percutaneous Coronary Intervention. Circulation Cardiovascular Interventions. 5(2). 227–236. 33 indexed citations
12.
Resnic, Frederic S., Sharon‐Lise T. Normand, Thomas C. Piemonte, et al.. (2011). Improvement in Mortality Risk Prediction After Percutaneous Coronary Intervention Through the Addition of a “Compassionate Use” Variable to the National Cardiovascular Data Registry CathPCI Dataset. Journal of the American College of Cardiology. 57(8). 904–911. 41 indexed citations
13.
Stamou, Sotiris C., Michael P. Robich, Robert Wolf, et al.. (2011). Effects of gender and ethnicity on outcomes after aortic valve replacement. Journal of Thoracic and Cardiovascular Surgery. 144(2). 486–492. 30 indexed citations
14.
Khurana, Rohit, Sharon‐Lise T. Normand, Treacy S. Silbaugh, et al.. (2010). INDEPENDENT US VALIDATION OF THE BRITISH COLUMBIA PCI RISK SCORE. Journal of the American College of Cardiology. 55(10). A134.E1261–A134.E1261.
15.
Charytan, David M., Manu Varma, Treacy S. Silbaugh, et al.. (2010). Long-term Clinical Outcomes Following Drug-Eluting or Bare-Metal Stent Placement in Patients With Severely Reduced GFR: Results of the Massachusetts Data Analysis Center (Mass-DAC) State Registry. American Journal of Kidney Diseases. 57(2). 202–211. 22 indexed citations
16.
Barringhaus, Kurt G., Katya Zelevinsky, Ann Lovett, Sharon‐Lise T. Normand, & Kalon K.L. Ho. (2010). Impact of Independent Data Adjudication on Hospital-Specific Estimates of Risk-Adjusted Mortality Following Percutaneous Coronary Interventions in Massachusetts. Circulation Cardiovascular Quality and Outcomes. 4(1). 92–98. 22 indexed citations
17.
Mauri, Laura, Treacy S. Silbaugh, Pallav Garg, et al.. (2008). Drug-Eluting or Bare-Metal Stents for Acute Myocardial Infarction. New England Journal of Medicine. 359(13). 1330–1342. 174 indexed citations
18.
Mauri, Laura, Treacy S. Silbaugh, Robert Wolf, et al.. (2008). Long-Term Clinical Outcomes After Drug-Eluting and Bare-Metal Stenting in Massachusetts. Circulation. 118(18). 1817–1827. 105 indexed citations
19.
Garg, Pallav, Sharon‐Lise T. Normand, Treacy S. Silbaugh, et al.. (2008). Drug-Eluting or Bare-Metal Stenting in Patients With Diabetes Mellitus. Circulation. 118(22). 2277–2285. 87 indexed citations
20.
Shahian, David M., et al.. (2007). Comparison of Clinical and Administrative Data Sources for Hospital Coronary Artery Bypass Graft Surgery Report Cards. Circulation. 115(12). 1518–1527. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Márcia Makdisse Breakdown of academic impact, for papers by Michael O’Donnell Breakdown of academic impact, for papers by Chee Tang Chin Breakdown of academic impact, for papers by John G. McGinnity Breakdown of academic impact, for papers by Anthony C. De Franco Breakdown of academic impact, for papers by Stanley W. Dziuban Breakdown of academic impact, for papers by Troels Yndigegn Breakdown of academic impact, for papers by Patrick Magee Breakdown of academic impact, for papers by Edwin Fonner Breakdown of academic impact, for papers by Laura G. Qualls
Rankless by CCL
2026